LONDON BROKER RATINGS: BofA cuts British Land; RBC raises Gym Group
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More
| Price | 1,816.50p on 16-01-2026 at 19:40:06 |
|---|---|
| Change | -31.50p -1.7% |
| Buy | 1,816.50p |
| Sell | 1,815.50p |
| Last Trade: | Unknown 1,000,000.00 at 1,839.40534p |
| Day's Volume: | 14,632,764 |
| Last Close: | 1,816.50p |
| Open: | 1,838.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,795.50p - 1,845.00p |
| 52wk Range: | 1,242.50p - 1,909.50p |
| Market Capitalisation: | £73.28b |
| VWAP: | 1,825.81199p |
| Shares in Issue: | 4.03b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 1,000,000 | 1,839.40534p | Ordinary Currency Conversion |
16:41:32 - 16-Jan-26 |
| Buy* | 900 | 1,816.50p | Automatic Execution |
16:36:24 - 16-Jan-26 |
| Buy* | 800 | 1,816.50p | Automatic Execution |
16:36:24 - 16-Jan-26 |
| Buy* | 1,100 | 1,816.50p | Automatic Execution |
16:36:24 - 16-Jan-26 |
| Buy* | 600 | 1,816.50p | Automatic Execution |
16:36:24 - 16-Jan-26 |
| Buy* | 10,320 | 1,816.50p | Automatic Execution |
16:36:24 - 16-Jan-26 |
| Sell* | 6,721 | 1,816.50p | Automatic Execution |
16:36:24 - 16-Jan-26 |
| Sell* | 11,542 | 1,816.50p | Automatic Execution |
16:36:15 - 16-Jan-26 |
| Sell* | 1,531 | 1,816.50p | SI Trade |
16:35:04 - 16-Jan-26 |
| Sell* | 288 | 1,816.50p | SI Trade |
16:35:04 - 16-Jan-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 16th Jan 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 15th Jan 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 13th Jan 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 7th Jan 2026 7:05 am | RNS | EC approval of Shingrix PFS |
| 7th Jan 2026 7:00 am | RNS | Positive phase 3 data for GSK's bepirovirsen |
| 6th Jan 2026 7:00 am | RNS | Exdensur approved in Japan |
| 5th Jan 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 5th Jan 2026 3:00 pm | RNS | Total Voting Rights |
| 5th Jan 2026 7:00 am | RNS | Nucala for adults with COPD approved in China |
| 22nd Dec 2025 3:30 pm | RNS | Director/PDMR Shareholding |